[1] Brock C,Yi Y,Papaluca T,et al.Exploring the feasibility of targeted chronic hepatitis B screening in the emergency department:A pilot study. Emerg Med Australas,2018,30(6):864-866. [2] Tanaka A,Inaguma D,Watanabe Y,et al.Hepatitis B virus infection among patients with chronic kidney disease who attended an educational program in Japan. Ther Apher Dial,2018,22(6):588-593. [3] Kawai K,Uchiyama M,Hester J.et al.Regulatory T cells for tolerance. Hum Immunol,2018,79(5):294-303. [4] Bai X,Shi H,Yang M,et al.Identification of key genes implicated in the suppressive function of human FOXP3+CD25+CD4+ regulatory T cells through the analysis of time series data. Mol Med Rep,2018,17(3):647-3657. [5] Schmidt A,Marabita F,Kiani NA,et al.Time-resolved transcriptome and proteome landscape of human regulatory T cell(Treg) differentiation reveals novel regulators of FOXP3. BMC Biol 2018,16(1):47. [6] Hashemi V,Farrokhi AS,Tanomand A,et al.Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population. Immunol Lett,2018,20(4):16-22. [7] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ. [8] 郑珍川,许夕海. 慢性乙型肝炎患者临床和肝组织病理学特点及影响肝纤维化因素分析. 实用肝脏病杂志,2018,21(5):713-716. [9] Liu M,Li S,Li MO.TGF-β control of adaptive immune tolerance:A break from Treg cells. Bioessays,2018,40(11): e1800063. [10] Leung CS,Yang KY,Li X,et al.Single-cell transcriptomics reveal that PD-1 mediates immune tolerance by regulating proliferation of regulatory T cells. Genome Med,2018,10(1):71. [11] Churlaud G,Abbara C,Vinot PA,et al. Pharmacodynamics of regulatory T cells in mice and humans treated with low-dose IL-2. J Allergy ClinImmunol,2018,142(4):1344-1346.e3. [12] Altmann DM.Regulatory T-cells:receptors,repertoires and roles in disease. Immunology,2018,155(2):153-154. [13] Palacz M,Tremellen K.High body Mass index is associated with an expansion of endometrial T Regulatory cell and macrophage populations. J Reprod Immunol,2018,12(9):36-39. [14] 张君,李风,范玉琛,等. 慢性乙型肝炎患者CD4+T细胞Foxp3基因甲基化状态的研究.中华实验和临床病毒学杂志,2018,32(1):32-37. [15] 董令,张爱华,朱凯,等. CD4+CD25+Foxp3+调节性T细胞在砷暴露大鼠肝脏中的表达差异及意义.中华地方病学杂志,2018,37(2):96-101. [16] Rojas J,Teran-Angel G,Barbosa L,et al.Activation-dependent mitochondrial translocation of Foxp3 in human hepatocytes. Exp Cell Res,2016,343(2):159-167. [17] Shi JY,Ma LJ,Zhang JW,et al.FOXP3is a HCC suppressor gene and acts through regulating the TGF-β/Smad2/3 signaling pathway. BMC Cancer,2017,17(1):648. [18] Ghosh S,Roy-Chowdhuri S,Kang K,et al.The transcription factor Foxp1 preserves integrity of an active Foxp3 locus in extrathymic Treg cells. Nat Commun,2018,9(1):4473. [19] 叶明. 原发性肝癌患者血清IL-6、IL-18和IL-18BP检测的意义. 实用肝脏病杂志,2016,19(3):354-355. [20] Jiang QQ,Han MF,Ma K,et al.Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis. World J Gastroenterol,2018,24(21):2300-2310. |